Salmonella/human S9 mutagenicity test: A collaborative study with 58 compounds

Mutagenesis

Volumn 20, Issue 3, 2005, Pages 217-228

  Hakura, Atsushi ^a   Shimada, Hiroyasu ^b   Nakajima, Madoka ^c   Sui, Hajime ^d   Kitamoto, Sachiko ^e   Suzuki, Satoshi ^f   Satoh, Tetsuo ^f  

^a EISAI CO LTD   (Japan)

^b DAIICHI SANKYO CO   (Japan)

^c Biosafety Research Center   (Japan)

^d HATANO RESEARCH INSTITUTE   (Japan)

^e SUMITOMO CHEMICAL CO LTD   (Japan)

^f BUILDING RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINOPYRENE; 1 NAPHTHYLAMINE; 1 NITRONAPHTHALENE; 1 NITROPYRENE; 1,2 DIMETHYLHYDRAZINE; 1,7 PHENANTHROLINE; 2 AMINOANTHRACENE; 2 FLUORENYLAMINE; 2 NITROFLUORENE; 2,4 DIAMINOTOLUENE; 2,4 DINITROTOLUENE; 3 METHYLCHOLANTHRENE; 3,3' DICHLOROBENZIDINE; 3,3' DICHLOROBENZIDINE 2HCL; 4 AMINOAZOBENZENE; 4 DIMETHYLAMINOAZOBENZENE; 4 NITROQUINOLINE 1 OXIDE; 4,4' METHYLENEDIANILINE; 6 CHRYSENAMINE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; 7,9 DIMETHYLBENZ[C]ACRIDINE; ACRYLAMIDE; ACRYLONITRILE; AFLATOXIN B1; AMINOAZOTOLUENE; AROMATIC AMINE; AURAMINE; AZATHIOPRINE; AZOBENZENE; BENZ[A]ANTHRACENE; BENZO[A]PYRENE; BETA NAPHTHOFLAVONE; CARCINOGEN; CHLORAMPHENICOL; CHRYSENE; CONGO RED; DACARBAZINE; DIBENZ[A,C]ANTHRACENE; DIBENZ[A,H]ANTHRACENE; DIETHYLNITROSAMINE; DIMETHYLNITROSAMINE; DIPROPYLNITROSAMINE; FURYLFURAMIDE; HYDRAZINE; HYDROCARBON; LEPIDINE; METRONIDAZOLE; N (2 FLUORENYL)ACETAMIDE; N NITROSO DI N BUTYLAMINE; NITROSAMINE; NITROSOMORPHOLINE; PHENANTHRENE; PHENOBARBITAL; PYRENE; QUERCETIN; QUINOLINE; SAFROLE; SODIUM NITRATE; SODIUM NITRITE; STYRENE; TOLIDINE; TRYPAN BLUE; UNCLASSIFIED DRUG;

AMES TEST; ARTICLE; BACTERIAL STRAIN; CHEMICAL STRUCTURE; DRUG MECHANISM; HUMAN; LIVER; METABOLIC ACTIVATION; MUTAGEN TESTING; MUTAGENIC ACTIVITY; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SALMONELLA TYPHIMURIUM; SPECIES DIVERSITY;

ANIMALS; BIOTRANSFORMATION; CELL FRACTIONATION; HUMANS; LIVER; MUTAGENESIS; MUTAGENICITY TESTS; MUTAGENS; RATS; SALMONELLA TYPHIMURIUM;

ANIMALIA; BACTERIA (MICROORGANISMS); SALMONELLA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 19544371891     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/gei029     Document Type: Article

References (50)

1. Maron,D.M. and Ames,B.N. (1983) Revised methods for the Salmonella mutagenicity test. Mutat. Res., 113, 173-215.
2. Mortelmans,K. and Zeiger,E. (2000) The Ames Salmonella/microsome mutagenicity test. Mutat. Res., 455, 29-60.
3. Ames,B.N., Durston,W.E., Yamasaki,E. and Lee,F.D. (1973) Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc. Natl Acad. Sci. USA, 70, 2281-2285.
4. Cooper,C.S. and Grover,P.L. (1990) Chemical Carcinogenesis and Mutagenesis I. Springer-Verlag, Berlin, Heidelberg.
5. Guengerich,F.P. and Shimada,T. (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol., 4, 391-407.
6. Guengerich,F.P. (2000) Metabolism of chemical carcinogens. Carcinogenesis, 21, 345-351.
7. Callander,R.D., Mackay,J.M., Clay,P., Elcombe,C.R. and Elliott,B.M. (1995) Evaluation of phenobarbital/β-naphthoflavone as an alternative S9-induction regime to Aroclor 1254 in the rat for use in in vitro genotoxicity assays. Mutagenesis, 10, 517-522.
8. Franco,S.G., Domínguez,G. and Pico,J.C. (1999) Alternatives in the induction and preparation of phenobarbital/naphthoflavone-induced S9 and their activation profiles. Mutagenesis, 14, 323-326.
9. Tang,T. and Friedman,M.A. (1977) Carcinogen activation by human liver enzymes in the Ames mutagenicity test. Mutat. Res., 46, 387-394.
10. 1 to mutagens by human liver. Biochem. Biophys. Res. Commun., 82, 348-355.
11. Bartsch,H., Malaveille,C., Barbin,A. and Planche,G. (1979) Mutagenic and alkylating metabolites of halo-ethylenes, chlorobutadienes and dichlorobutenes produced by rodent or human liver tissues. Evidence for oxirane formation by P450-linked microsomal mono-oxygenases. Arch. Toxicol., 41, 249-277.
12. Dybing,E., Bahr,C.v., Aune,T., Glaumann,H., Levitt,D.S. and Thorgeirsson,S.S. (1979) In vitro metabolism and activation of carcinogenic aromatic amines by subcellular fractions of human liver. Cancer Res., 39, 4206-4211.
13. Sabadie,N., Malaveille,C., Camus,A-M. and Bartsch,H. (1980) Comparison of the hydroxylation of benzo(a)pyrene with the metabolism of vinyl chloride, N-nitrosomorpholine, and N-nitroso-N′-methylpiperazine to mutagens by human and rat liver microsomal fractions. Cancer Res., 40, 119-126.
14. Phillipson,C.E. and Ioannides,C. (1983) Activation of aromatic amines to mutagens by various animal species including man. Mutat. Res., 124, 325-336.
15. Phillipson,C.E. and Ioannides,C. (1984) A comparative study of the bioactivation of nitrosamines to mutagens by various animal species including man. Carcinogenesis, 5, 1091-1094.
16. Phillipson,C.E. and Ioannides,C. (1989) Metabolic activation of poly-cyclic aromatic hydrocarbons to mutagens in the Ames test by various animal species including man. Mutat. Res., 211, 147-151.
17. Beaune,P., Lemestré-Cornet,R., Kremers,P., Albert,A. and Gielen,J. (1985) The Salmonella/mammalian microsome mutagenicity test: comparison of human and rat livers as activating systems. Mutat. Res., 156, 139-146.
18. Le,J., Jung,R. and Kramer,M. (1985) Dedicated to Prof. Med. Helmut Kewitz in honour of his 65th birthday: effects of using liver fractions from different mammals, including man, on results of mutagenicity assays in Salmonella typhimurium. Food Chem. Toxicol., 23, 695-700.
19. Mori,Y., Yamazaki,H., Toyoshi,K., Maruyama,H. and Konishi,Y. (1986) Activation of carcinogenic N-nitrosopropylamines to mutagens by lung and pancreas S9 fractions from various animal species and man. Mutat. Res., 160, 159-169.
20. Neis,J.M., Yap,S.H., van Gemert,P.J.L., Roelofs,H.M.J., Bos,R.P. and Henderson,P.Th. (1986) Activation of mutagens by hepatocytes and liver 9000× g supernatant from human origin in the Salmonella typhimurium mutagenicity assay: comparison with rat liver preparations. Mutat. Res., 164, 41-51.
21. Raineri,R., Andrews,A.W. and Poiley,J.A. (1986) Effect of donor age on the levels of activity of rat, hamster and human liver S9 preparations in the Salmonella mutagenicity assay. J. Appl. Toxicol., 6, 101-108.
22. Yamazaki,H., Mori,Y., Toyoshi,K., Nagai,H., Koda,A. and Konishi,Y. (1986) A comparative study of the mutagenic activation of N-nitro-sopropylamines by various animal species and man: evidence for a cytochrome P-450 dependent reaction. Jpn. J. Cancer Res. (Gann), 77, 107-117.
23. Jongeneelen,F.J., Akker,W.v.d., Bos,R.P., Anzion,R.B.M., Theuws,J.L.G., Roelofs,H.M.J. and Henderson,P.Th. (1988) 1-Hydroxypyrene as an indicator of the mutagenicity of coal tar after activation with human liver preparations. Mutat. Res., 204, 195-201.
24. Smith,A.J. and Chipman,J.K. (1988) Inter-individual variation in the mutagenic activation of 2-acetylaminofluorene by human liver in relation to animal metabolic models. Mutagenesis, 3, 323-328.
25. Johnson,T.E., Umbenhauer,D.R. and Galloway,S.M. (1996) Human liver S-9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/β-naphthoflavone or aroclor 1254 induced rat S-9. Environ. Mol. Mutagen., 28, 51-59.
26. Hakura,A., Suzuki,S. and Satoh,T. (1999) Advantage of the use of human liver S9 in the Ames test. Mutat. Res., 438, 29-36.
27. Hakura,A., Suzuki,S., Sawada,S., Motooka,S. and Satoh,T. (2002) An improvement of the Ames test using a modified human liver S9 preparation. J. Pharmacol. Toxicol. Methods, 46, 169-172.
28. Hakura,A., Suzuki,S., Sawada,S., Sugihara,T., Hori,Y., Uchida,K., Kerns,W.D., Sagami, F., Motooka,S. and Satoh,T. (2003) Use of human liver S9 in the Ames test: assay of 3 procarcinogens using human S9 derived from multiple donors. Regul. Toxicol. Pharmacol., 37, 20-27.
29. Hakura,A., Suzuki,S. and Satoh,T. (2004) Improvement of the Ames test using human liver S9 preparation. In Yan.Z. and Caldwell,G.W. (eds), Optimization in Drug Discover: In-vitro Methods. Humana Press, Totawa, pp. 325-336.
30. Lijinsky,W. and Andrews,A.W. (1983) The superiority of hamster liver microsomal fraction of activating nitrosamines to mutagens in Salmonella typhimurium. Mutat. Res., 111, 135-144.
31. Prival,M.J., Bell,S.J., Mitchell,V.D., Peiperl,M.D. and Vaughan,V.L. (1984) Mutagenicity of benzidine and benzidine-congener dyes and selected monoazo dyes in a modified Salmonella assay. Mutat. Res., 136, 33-47.
32. 6methylguanine DNA methyltransferases and highly sensitive to mutagenic alkylating agents. Mutat. Res., 381, 15-24.
33. Omura,T. and Sato,R. (1964) The carbon monooxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem., 239, 2370-2378.
34. Ikeda,T., Nishimura,K., Taniguchi,T. et al. (2001) In vitro evaluation of drug interaction caused by enzyme inhibition - HAB protocol. Xenobiol. Metabol. Dispos., 16, 115-126.
35. Synder,S., Hsu,I.C. and Trump,B.F. (1987) Comparison of metabolic activation of carcinogens in human, rat, and hamster hepatocytes. Mutat. Res., 182, 31-39.
36. Kataoka,K., Kinouchi,T. and Ohnishi,Y. (1991) Species differences in metabolic activation and inactivation of 1-nitropyrene in the liver. Cancer Res., 51, 3919-3924.
37. Cooper,M.T. and Porter,T.D. (2000) Mutagenicity of nitrosamines in methyltransferase-deficient strains of Salmonella typhimurium coexpressing human cytochrome P450 2E1 and reductase. Mutat. Res., 454, 45-52.
38. Kushida,H., Fujita,K., Suzuki,A., Yamada,M., Endo,T., Nohmi,T. and Kamataki,T. (2000) Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. Carcinogenesis, 21, 1227-1232.
39. Fujita,K. and Kamataki,T. (2001) Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase. Environ. Mol. Mutagen., 38, 339-346.
40. Josephy,P.D., Batty,S.M. and Boverhof,D.R. (2001) Recombinant human P450 forms 1A1, 1A2, and 1B1 catalyze the bioactivation of heterocyclic amine mutagens in Escherichia coli lacZ strains. Environ. Mol. Mutagen., 38, 12-18.
41. Czygan,P., Greim,H., Garro,A.J., Hutterer,F., Rudick,J., Schaffner,F. and Popper,H. (1973) Cytochrome P-450 content and the ability of liver microsomes from patients undergoing abdominal surgery to alter the mutagenicity of a primary and a secondary carcinogen. J. Natl Cancer Inst., 51, 1761-1764.
42. Boobis,A.R., Brodie,M.J., McManus,M.E., Staiano,N., Thorgeirsson,S.S., and Davies,D.S. (1982) Metabolism and mutagenic activation of 2-acetylaminofluorene by human liver and lung. Adv. Exp. Med. Biol., 136B, 1193-1201.
43. Yamazoe,Y., Abu-Zeid,M., Yamauchi,K. and Kato,R. (1988) Metabolic activation of pyrolysate arylamines by human liver microsomes: possible involvement of a P-488-H type cytochrome P-450. Jpn. J. Cancer Res., 79, 1159-1167.
44. Kitada,M., Taneda,M., Ohta,K., Nagashima,K., Itahashi,K. and Kamataki,T. (1990) Metabolic activation of aflatoxin BI and 2-amino-3-methylimidazo[4,5-f] quinoline by human adult and fetal livers. Cancer Res., 50, 2641-2645.
45. Marczylo,T. and Ioannides,C. (1994) Bioactivation of 6-aminochrysene by animal and human hepatic preparations: contributions of microsomal and cytosolic enzyme systems. Mutagenesis, 9, 233-239.
46. Yamada,K., Suzuki,T., Hakura,A., Mizutani,T. and Saeki, K. (2004) Metabolic activation of 10-aza-substituted benzo[a]pyrene by cytochrome P450 1A2 in human liver microsomes. Mutat. Res., 557, 159-165.
47. Prival,M.J. and Mitchell,V.D. (1982) Analysis of a method for testing azo dyes for mutagenic activity in Salmonella typhimurium in the presence of flavin mononucleotide and hamster liver S9. Mutat. Res., 97, 103-116.
48. Distlerath,L.M. and Guengerich,F.P. (1987) Enzymology of human liver cytochromes P-450. Guengerich,F.P. (ed.), Mammalian Cytochromes P-450. CRC Press, Boca Raton, FL, Vol. 1, pp. 133-198.
49. Shimada,T. and Okuda,Y. (1988) Metabolic activation of environmental carcinogens and mutagens by human liver microsomes. Biochem. Pharmacol., 37, 459-465.
50. Brandon,E.F.A., Raap,C.D., Meijerman,I., Beijnen,J.H. and Schellens,J.H.M. (2003) An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol. Appl. Pharmacol., 189, 233-246.